Literature DB >> 17179674

Complications of 2-D echocardiography guided transfemoral right ventricular endomyocardial biopsy.

Juyup Han1, Yongwhi Park, Hyunsang Lee, Hyunjae Kang, Hyungseop Kim, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung-Chull Chae, Jae-Eun Jun, Wee-Hyun Park.   

Abstract

Endomyocardial biopsy (EMBx) is a useful tool for diagnosing various cardiac pathologies. However, the routine use of EMBx has not gained widespread acceptance due to the possible complications related to the EMBx. Thus, not much information is available on the complications related to the EMBx. We prospectively evaluated 90 consecutive patients who underwent 2-D echocardiography guided transfemoral right ventricular EMBx at Kyungpook National University Hospital between March 2002 and November 2005 to determine the incidence, nature and subsequent management of complications related to EMBx. The clinical diagnoses before the EMBx were arrhythmogenic right ventricular dysplasia in 54, dilated cardiomyopathy in 19, Brugada syndrome in 9, myocarditis in 6 and miscellaneous in 2 patients. The overall major complication rate was 5.6% and no procedure-related mortality occurred. Myocardial perforation (n=3), which was the most frequent complication, did not progress to cardiac tamponade requiring pericardiocentesis in any patient. Hemodynamically unstable ventricular tachycardia occurred in 1 patient. New and persistent right bundle branch block occurred in another. Our findings suggest that 2-D echocardiography guided transfemoral right ventricular EMBx is a relatively safe procedure.

Entities:  

Mesh:

Year:  2006        PMID: 17179674      PMCID: PMC2721952          DOI: 10.3346/jkms.2006.21.6.989

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  21 in total

1.  Echo-controlled endomyocardial biopsy.

Authors:  T Ragni; L Martinelli; C Goggi; G Speziali; M Rinaldi; G Roda; C Pederzolli; P A Intili; A Raisaro; M Viganò
Journal:  J Heart Transplant       Date:  1990 Sep-Oct

2.  Ruptured chordae tendineae of the tricuspid valve as a complication of endomyocardial biopsy in heart transplant patients.

Authors:  A C Braverman; S E Coplen; G H Mudge; R T Lee
Journal:  Am J Cardiol       Date:  1990-07-01       Impact factor: 2.778

3.  Clinical evaluation of transvenous catheter technique for endomyocardial biopsy.

Authors:  N Ali; V J Ferrans; W C Roberts; R A Massumi
Journal:  Chest       Date:  1973-03       Impact factor: 9.410

4.  Tricuspid valve chordal tissue in endomyocardial biopsy specimens of patients with significant tricuspid regurgitation.

Authors:  Lisa Mielniczuk; Haissam Haddad; Ross A Davies; John P Veinot
Journal:  J Heart Lung Transplant       Date:  2005-10       Impact factor: 10.247

5.  Techniques for right and left ventricular endomyocardial biopsy.

Authors:  J W Mason
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

6.  Echo-guided endomyocardial biopsy in heart transplant recipients.

Authors:  Helena Bedanova; Josef Necas; Erik Petrikovits; Petr Pokorny; Sylva Kovalova; Petr Malik; Jiri Ondrasek; Jan Cerny
Journal:  Transpl Int       Date:  2004-10-16       Impact factor: 3.782

7.  The femoral venous approach to endomyocardial biopsy: comparison with internal jugular and transarterial approaches.

Authors:  J L Anderson; H W Marshall
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

8.  Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy.

Authors:  Hossein Ardehali; Atif Qasim; Thomas Cappola; David Howard; Ralph Hruban; Joshua M Hare; Kenneth L Baughman; Edward K Kasper
Journal:  Am Heart J       Date:  2004-05       Impact factor: 4.749

9.  Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation.

Authors:  P A Tucker; B S Jin; C M Gaos; B Radovancevic; O H Frazier; S Wilansky
Journal:  J Heart Lung Transplant       Date:  1994 May-Jun       Impact factor: 10.247

Review 10.  Endomyocardial biopsy.

Authors:  R E Fowles; J W Mason
Journal:  Ann Intern Med       Date:  1982-12       Impact factor: 25.391

View more
  7 in total

Review 1.  Echocardiographic guidance for diagnostic and therapeutic percutaneous procedures.

Authors:  Cam Tu Nguyen; Eunice Lee; Huai Luo; Robert J Siegel
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

2.  Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures.

Authors:  Se Yong Jang; Yongkeun Cho; Joon Hyuck Song; Sang Soo Cheon; Sun Hee Park; Myung Hwan Bae; Jang Hoon Lee; Dong Heon Yang; Hun Sik Park; Shung Chull Chae
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

Review 3.  Current status of endomyocardial biopsy.

Authors:  Aaron M From; Joseph J Maleszewski; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

4.  Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; Cornelia Piper; Olaf Sowade; Finn Waagstein; Joachim-Friedrich Kapp; Karl Wegscheider; Georg Groetzbach; Matthias Pauschinger; Felicitas Escher; Eloisa Arbustini; Harald Siedentop; Uwe Kuehl
Journal:  Clin Res Cardiol       Date:  2016-04-25       Impact factor: 5.460

5.  Demographic features and prevalence of myocarditis in patients undergoing transarterial endomyocardial biopsy for unexplained cardiomyopathy.

Authors:  Ayman K M Hassan; Doaa Ahmed Fouad; Abeer Refaiy
Journal:  Egypt Heart J       Date:  2016-10-10

Review 6.  Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Updated Review of Diagnosis and Management.

Authors:  Yasar Sattar; Hafez Mohammad Abdullah; Elham Neisani Samani; Madhura Myla; Waqas Ullah
Journal:  Cureus       Date:  2019-08-13

7.  Importance of endomyocardial biopsy in patients with myocarditis: A case report.

Authors:  Özge Çetinarslan; Refika Hüral; Emir Özgürbarış Ökçün
Journal:  Anatol J Cardiol       Date:  2019-11       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.